Reference 2019-185

REF:           2019-185

Subject:       Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

    

 

Request:

1) How many patients with breast implant associated ALCL (BIA-ALCL) have been treated within the trust since 2000? Please break down the figures by what year the patient was treated and which hospital the patient was treated at, where possible.

2) How many of these cases were reported to the Medicines and Healthcare products Regulatory Agency (MHRA)?

3) Have any patients with BIA-ALCL died while under treatment within the trust? If so, please give the year and the hospital if possible and whether this adverse event was reported to the MHRA.

 

Response:

1) How many patients with breast implant associated ALCL (BIA-ALCL) have been treated within the trust since 2000? Please break down the figures by what year the patient was treated and which hospital the patient was treated at, where possible. There have been no recorded patients with breast implant associated ALCL (BIA-ALCL) treated at the trust during the period specified.

 

2) How many of these cases were reported to the Medicines and Healthcare products Regulatory Agency (MHRA)?
3) Have any patients with BIA-ALCL died while under treatment within the trust? If so, please give the year and the hospital if possible and whether this adverse event was reported to the MHRA.